Latest filing published 01 Aug 2008 for NOVAVAX INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James B. Tananbaum: trading record in brief
James B. Tananbaum has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Critical Therapeutics Inc, Vanda Pharmaceuticals Inc. and Jazz Pharmaceuticals plc. The record holds 30 filings, for trades running from 18 April 2006 to 31 July 2008.
In open-market terms, that means 3 purchases on one side and 14 sales worth €19.4M on the other. The amount is not disclosed for 3 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants. 2008 to date brings 3 purchases and no sales.
Most recently, on 1 August 2008, the filings show an open-market purchase in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James B. Tananbaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,181 sharesCommon StockSEC:0001209191-08-044835:0Canonical exit: 29 Oct 2008 (T+90)
- 2,855 sharesCommon StockSEC:0001209191-08-043439:1Canonical exit: 19 Oct 2008 (T+90)
- 187,479 sharesCommon StockSEC:0001209191-08-043439:0Canonical exit: 19 Oct 2008 (T+90)
- 195,751 shares@ US$2.29Common StockSEC:0001209191-07-037642:0
- 2,400 shares@ US$2.50Common StockSEC:0001209191-07-036906:0
- 60,910 shares@ US$2.38Common StockSEC:0001209191-07-036906:1
- 300,000 shares@ US$2.23Common StockSEC:0001209191-07-036906:2
- 330,794 shares@ US$2.69Common StockSEC:0001209191-07-036260:0
- 1,000 shares@ US$2.68Common StockSEC:0001209191-07-036260:1
- 288,000 shares@ US$2.50Common StockSEC:0001209191-07-036260:2
- 660,849 sharesCommon StockSEC:0001209191-07-035557:0
- 10,063 sharesCommon StockSEC:0001209191-07-035557:1
- 554,801 sharesCommon StockSEC:0001209191-07-035557:2
- 8,448 sharesCommon StockSEC:0001209191-07-035557:3
- 398,894 shares@ US$2.90Common StockSEC:0001209191-07-035430:0
- 315,773 shares@ US$2.76Common StockSEC:0001209191-07-035430:1
- 387,500 shares@ US$2.66Common StockSEC:0001209191-07-035430:2
- 727,512 shares@ US$26.56Common StockSEC:0001209191-06-064679:0
- 11,079 shares@ US$26.56Common StockSEC:0001209191-06-064679:1
- 6,775 shares@ US$25.27Common StockSEC:0001209191-06-064679:2
- 103 shares@ US$25.27Common StockSEC:0001209191-06-064679:3
- 907,332 shares0Common StockSEC:0001209191-06-058202:0
- 13,817 shares0Common StockSEC:0001209191-06-058202:1
- 2,303 shares0Common StockSEC:0001209191-06-058202:2
- 134,688 sharesCommon StockSEC:0001181431-06-052821:0
25 of 30 declarations
